Axa S.A. Intercept Pharmaceuticals, Inc. Transaction History

Axa S.A.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$19.33 - $37.75 $195,232 - $381,275	-10,100 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$24.48 - $42.47 $247,248 - $428,947	10,100 New	10,100 $249,000
Q2 2019 Aug 13, 2019	SELL	$77.77 - $120.68 $2.31 Million - $3.59 Million	-29,755 Closed	0 $0
Q3 2018 Nov 08, 2018	BUY	$88.49 - $127.55 $2.63 Million - $3.8 Million	29,755 New	29,755 $3.76 Million
Q1 2018 May 14, 2018	SELL	$52.72 - $67.25 $1.3 Million - $1.66 Million	-24,632 Closed	0 $0
Q4 2017 Feb 13, 2018	SELL	$58.2 - $72.76 $931 - $1,164	-16 Reduced 0.06%	24,632 $1.44 Million
Q3 2017 Nov 13, 2017	BUY	$57.01 - $118.75 $1.41 Million - $2.93 Million	24,648	24,648 $1.43 Million

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Axa S.A., based on Form 13F filings with the SEC.

Stay updated on Axa S.A. with notifications on news.